Fifth Third Wealth Advisors’s ResMed RMD Stock Holding History

Fifth Third Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$835K	Sell	4,284 -178	-4%	-$36.9K	0.02%	339
2026 Q1	$1M	Buy	4,462 +152	+4%	+$37.9K	0.03%	273
2025 Q4	$1.04M	Buy	4,310 +1,009	+31%	+$258K	0.04%	253
2025 Q3	$904K	Buy	3,301 +1,969	+148%	+$538K	0.03%	259
2025 Q2	$344K	Sell	1,332 -83	-6%	-$19.8K	0.01%	478
2025 Q1	$317K	Buy	1,415 +117	+9%	+$27.3K	0.02%	477
2024 Q4	$297K	Sell	1,298 -15	-1%	-$3.61K	0.02%	494
2024 Q3	$321K	Sell	1,313 -28	-2%	-$6.26K	0.02%	443
2024 Q2	$257K	Buy	+1,341	New	+$272K	0.02%	477

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Fifth Third Wealth Advisors's RMD Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its ResMed (RMD) stake by 4% in Q2 2026, selling an estimated $36.9K and leaving 4,284 shares worth $835K. The position accounts for 0.02% of the portfolio, ranked #339.

Fifth Third Wealth Advisors first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.04M in Q4 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Fifth Third Wealth Advisors held 4,284 shares of ResMed worth $835K as of Q2 2026.
Fifth Third Wealth Advisors sold 178 ResMed shares in Q2 2026, an estimated $36.9K.
ResMed made up 0.02% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #339 holding.
Fifth Third Wealth Advisors first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
Fifth Third Wealth Advisors's ResMed position peaked at $1.04M in Q4 2025.
139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.